IceCure Medical Registration Statement Effective March 23, 2026
Ticker: ICCM · Form: EFFECT · Filed: Mar 24, 2026 · CIK: 0001584371
| Field | Detail |
|---|---|
| Company | Icecure Medical Ltd. (ICCM) |
| Form Type | EFFECT |
| Filed Date | Mar 24, 2026 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: registration-statement, capital-raise, equity-offering
TL;DR
**IceCure's registration is effective, clearing the way for a potential new stock offering.**
AI Summary
The SEC has declared IceCure Medical Ltd.'s registration statement (File No. 333-288062) effective as of March 23, 2026. This means the company can now proceed with its planned offering of securities, which could include selling new shares to raise capital. For investors, this is a green light for IceCure to potentially fund its operations or expansion, but it also means there could be dilution if new shares are issued, impacting the value of existing shares.
Why It Matters
This filing signals that IceCure Medical Ltd. has met the SEC's requirements to offer new securities, potentially allowing them to raise significant capital for growth or operations. Investors should monitor for details of the actual offering, as it could impact share price through dilution or by funding new initiatives.
Risk Assessment
Risk Level: medium — While enabling capital raising, an offering could dilute existing shareholders, making it a medium risk for current investors.
Analyst Insight
Investors should look for subsequent filings (like a prospectus supplement or 424B) that detail the terms, size, and pricing of the actual offering to understand potential dilution and capital infusion.
Key Players & Entities
- IceCure Medical Ltd. (company) — the filer whose registration statement became effective
- SEC (company) — the regulatory body that declared the registration statement effective
- 0001584371 (person) — CIK for IceCure Medical Ltd.
- 333-288062 (person) — File Number for the registration statement
- 2026-03-23 (person) — Effectiveness Date of the registration statement
Forward-Looking Statements
- IceCure Medical Ltd. will proceed with a public offering of securities. (IceCure Medical Ltd.) — high confidence, target: 2026-12-31
FAQ
What is the significance of an 'EFFECT' filing for IceCure Medical Ltd.?
An 'EFFECT' filing, specifically for IceCure Medical Ltd. (CIK: 0001584371) with File No. 333-288062, means that the SEC has declared their previously filed registration statement effective as of March 23, 2026. This allows the company to proceed with the offering of securities described in that registration statement, such as selling new shares to the public.
When did IceCure Medical Ltd.'s registration statement become effective?
According to the filing, the effectiveness date for IceCure Medical Ltd.'s registration statement (File No. 333-288062) was March 23, 2026, and it was accepted by the SEC on March 24, 2026, at 00:15:10.
Filing Stats: 36 words · 1 min read · ~1 pages · Grade level 11.5 · Accepted 2026-03-24 00:15:10
Filing Documents
- primary_doc.html (EFFECT)
- primary_doc.xml (EFFECT) — 1KB
- 9999999995-26-000904.txt ( ) — 2KB
From the Filing
Notice of Effectiveness UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Notice of Effectiveness Effectiveness Date: March 23, 2026 Submission Type: POS AM CIK: Company Name: IceCure Medical Ltd. File Number: 333-288062